1:55 PM
 | 
Apr 30, 2018
 |  BC Extra  |  Financial News

Alzheon postpones NASDAQ IPO

Alzheon Inc. (Framingham, Mass.) has postponed its IPO, according to a statement to BioCentury. In March, the Alzheimer's disease company had filed for a listing on NASDAQ underwritten by Citigroup, Piper Jaffray, Canaccord Genuity and JMP Securities (see BioCentury...

Read the full 177 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Extra

Article Purchase

$50 USD
More Info >